Publications by authors named "Thomas Ferro"

Claim this Profile
R
Real-World Treatment Patterns of Patients with Basal Cell Carcinoma Using Sonidegib and Vismodegib: Discontinuation Rates and Clinical Conditions During Treatment.
Mark G Lebwohl, Darrell S Rigel, Zeynep Eroglu, Victoria E Barghout, Deepshekhar Gupta, Thomas J Ferro

Dermatol Ther (Heidelb)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis.
Mark G Lebwohl, André Carvalho, Akihiko Asahina, Jianzhong Zhang, Mir Sohail Fazeli, Thomas Ferro

Dermatol Ther (Heidelb)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Systematic Review and Network Meta-analysis.
Mark G Lebwohl, André Carvalho, Akihiko Asahina, Jianzhong Zhang, Mir Sohail Fazeli, Thomas Ferro

Dermatol Ther (Heidelb)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in Patient-reported Symptoms and Satisfaction with Tildrakizumab in a Real-world Study in Patients with Moderate-to-severe Plaque Psoriasis.
Juan Gabriel Vasquez, Jayme M Heim, Tina Bhutani, John Koo, Jacob Mathew, Thomas Ferro

J Clin Aesthet Dermatol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tildrakizumab Real-World Effectiveness and Safety Over 64 Weeks in Patients With Moderate-to-Severe Plaque Psoriasis.
Jayme Heim, J Gabriel Vasquez, Tina Bhutani, John Koo, Jacob Mathew, Thomas Ferro

J Drugs Dermatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in Psoriasis-Related Work Productivity with Tildrakizumab: Results from a Phase 4 Real-World Study in Patients with Moderate-to-Severe Plaque Psoriasis.
Tina Bhutani, John Koo, Jayme Heim, Neal Bhatia, Jacob Mathew, Thomas Ferro

Dermatol Ther (Heidelb)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab Efficacy in Patients with Type 2 Asthma with and without Elevated Blood Neutrophils.
Eugene R Bleecker, Reynold A Panettieri, Njira L Lugogo, Jonathan Corren, Nadia Daizadeh, Thomas J Ferro

J Immunol Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Minorities at the Highest Risk of Uncontrolled Moderate-to-Severe Asthma: A United States Electronic Health Record Analysis.
Maureen George, Carlos A Camargo, Autumn Burnette, Yuning Chen, Ajinkya Pawar, Thomas J Ferro

J Asthma Allergy· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezacaftor/ivacaftor in people with cystic fibrosis who stopped lumacaftor/ivacaftor due to respiratory adverse events.
Carsten Schwarz, Sivagurunathan Sutharsan, Ralph Epaud, Ross C Klingsberg, Rainald Fischer, Thomas J Ferro

J Cyst Fibros· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Ran-Out Status of Inhaled Short-Acting Beta-Agonists in Emergency Department Patients with Acute Asthma: 1996-1998 versus 2015-2017.
Tadahiro Goto, Carlos A Camargo, Catalina Gimenez-Zapiola, Daniel J Pallin, Nathan I Shapiro, Thomas J Ferro

J Allergy Clin Immunol Pract· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical burden of asynchrony in patients with asthma when using metered-dose inhalers for control.
Thomas J Ferro, Agnes S Sundaresan, James M Pitcavage, Jasmina I Ivanova, Luke Schmerold

Allergy Asthma Proc· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world health care utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir HFA) with and without integrated dose counters.
Edward M Kerwin, Thomas J Ferro, Rinat Ariely, Debra E Irwin, Ruchir Parikh

J Asthma Allergy· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beclomethasone Dipropionate Nasal Aerosol in Patients with Perennial Allergic Rhinitis (BALANCE) study: 6-month results.
Donald Bukstein, Ruchir Parikh, Sherrine Eid, Thomas Ferro, Jean-Pierre Morello

Allergy Asthma Proc· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical cohort study examining comparative effectiveness of albuterol inhalers with and without integrated dose counter for patients with asthma or chronic obstructive pulmonary disease.
David B Price, Anna Rigazio, Mary Buatti Small, Thomas J Ferro

J Asthma Allergy· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of expired and empty quick-relief asthma inhalers: The Asthma and Allergy Foundation of America's Asthma Inhaler Design Survey.
William W Storms, Mike Tringale, Thomas J Ferro

Allergy Asthma Proc· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation.
Jill A Ohar, Glenn D Crater, Amanda Emmett, Thomas J Ferro, Andrea N Morris

Respir Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD.
François Maltais, Donald A Mahler, Véronique Pepin, Eric Nadreau, Glenn D Crater, Thomas J Ferro

Eur Respir J· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overview of national treatment guidelines for common respiratory tract infections.
Thomas J Ferro

Am J Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving adherence with antimicrobial therapy for respiratory tract infections: a discussion of directly observed therapy (DOT) and short-course therapies.
Douglas B Schwartz, Alan Adler, Anthony P Dasaro, Ronald J DeBellis, Robbin Dick, Thomas J Ferro

Am J Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index and response to asthma therapy: fluticasone propionate/salmeterol versus montelukast.
Carlos A Camargo, Louis-Philippe Boulet, E Rand Sutherland, William W Busse, Steven W Yancey, Thomas J Ferro

J Asthma· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(ADP-ribose) polymerase-1 regulates vimentin expression in lung cancer cells.
Shijian Chu, Haishan Xu, Thomas J Ferro, Paola X Rivera

Am J Physiol Lung Cell Mol Physiol· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a hydrogen peroxide-induced PP1-JNK1-Sp1 signaling pathway for gene regulation.
Shijian Chu, Thomas J Ferro

Am J Physiol Lung Cell Mol Physiol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sp1: regulation of gene expression by phosphorylation.
Shijian Chu, Thomas J Ferro

Gene· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interferon-gamma regulates ClC-2 chloride channel in lung epithelial cells.
Shijian Chu, Carol J Blaisdell, Penelope Bamford, Thomas J Ferro

Biochem Biophys Res Commun· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction.
Sonja K Fredrickson, Thomas J Ferro, Andrew C Schutrumpf

Diabetes Care· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis